1. Home
  2. CBAN vs ANNX Comparison

CBAN vs ANNX Comparison

Compare CBAN & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Colony Bankcorp Inc.

CBAN

Colony Bankcorp Inc.

HOLD

Current Price

$19.33

Market Cap

436.3M

Sector

Finance

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.64

Market Cap

730.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBAN
ANNX
Founded
1975
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
436.3M
730.4M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
CBAN
ANNX
Price
$19.33
$5.64
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$16.50
AVG Volume (30 Days)
164.3K
2.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.47%
N/A
EPS Growth
9.68
42.94
EPS
1.17
N/A
Revenue
N/A
N/A
Revenue This Year
$35.41
N/A
Revenue Next Year
$4.84
N/A
P/E Ratio
$16.58
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.99
$1.29
52 Week High
$21.46
$7.18

Technical Indicators

Market Signals
Indicator
CBAN
ANNX
Relative Strength Index (RSI) 40.64 51.82
Support Level $15.96 $4.77
Resistance Level $21.25 $7.18
Average True Range (ATR) 0.54 0.35
MACD -0.14 0.06
Stochastic Oscillator 16.18 46.85

Price Performance

Historical Comparison
CBAN
ANNX

About CBAN Colony Bankcorp Inc.

Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: